Informa Healthcare: journal news

Showing posts with label journal news. Show all posts

Monday, 13 December 2010

A Special Issue with a Special Offer: Downloads for Donations*

The International Journal of Hyperthermia marked Breast Cancer Awareness Month with a timely Special Issue on the use of hyperthermia as a treatment for this disease. To mark the Special Issue, Informa Healthcare is donating $1 for each download* of the issue’s free-access articles to Susan G. Komen for the Cure®. Susan G. Komen for the Cure® is the world's largest breast cancer charity dedicated to education and research about causes, treatment and the search for a cure.

To date, there have been 3,512 downloads of articles from the Special Issue!

Hyperthermia, as its name suggests, involves raising tumor temperature and the treatment is used to fight disease. Modern advancements in hyperthermia biology have led to refinements for individualized thermochemotherapy approaches to treatments as well as interesting potential for exploiting hyperthermia in conjunction with cancer vaccines. Interest in hyperthermia as a treatment for breast cancer has led to significant advances and research activity which, in turn, has had a significant impact on treatment protocol. Thanks to the volume of research and the impact of published articles, the National Comprehensive Cancer Network (NCCN) now includes hyperthermia in their Breast Cancer Guidelines as a treatment for recurrent cancer.

“The breadth of contributions from the authors in this issue highlights the tremendous progress that has occurred in the role of hyperthermia for the treatment of breast cancer,” says Dr Joan Bull, Co-Guest Editor of the Special Edition.. “This subject has garnered broad national and international interest in this cutting-edge treatment for one of the world’s most high-profile and, unfortunately, prolific diseases.” To view the complete list of articles in the issue, please click here. For more information on the Special Issue, please contact Senior Managing Editor Didi Peng.

*This applies to a full text download of any article from the Special Issue (Volume 26 Issue 7) with a maximum donation of up to $1,500.00.

Wednesday, 8 December 2010

Of abstract importance – new abstract style for 2011

The Expert Opinion journals recognise how important an article's abstract is in drawing in the interested reader. The clearer and more insightful the abstract, the more interest, and potentially more citations, the manuscript will attract. For original research and systematic reviews, structured abstracts are typically required, with guidance on how to prepare these provided by the CONSORT Group. For review articles with free, unstructured abstracts, however, it can be difficult to know how best to present the abstract and what information to include to best represent the full paper. To help authors prepare fitting abstracts and to provide consistency for readers across the Expert Opinion series, in 2011 we are requesting authors include the following in their abstracts for review articles:

Introduction - describing the significance of the topic and reason for the review
Areas covered - describing the research discussed and the literature review undertaken
Expert opinion - summarising the article's 'Expert Opinion' section, a unique feature of all Expert Opinion reviews in which the author goes beyond the conclusion to provide their own personal view of the field

Saturday, 2 August 2008

Expert Opinion 2007 Impact Factors

The 2007 ISI Impact Factors have just been released, and Expert Opinion has had a good year. Expert Opinion on Emerging Drugs has now received its first Impact Factor, emerging with a strong first showing of 2.725. Expert Opinion on Therapeutic Targets enjoyed the greatest increase from 2006, jumping from 2.662 to 3.333, while Expert Opinion on Investigational Drugs continues to have the highest Impact Factor and total citations among the Expert Opinion journals.

Expert Opinion on Investigational Drugs: 3.667 (up from 3.174)
Expert Opinion on Therapeutic Targets: 3.333 (up from 2.662)
Expert Opinion on Biological Therapy: 2.815 (up from 2.705)
Expert Opinion on Emerging Drugs: 2.725 (first Impact factor for EOED)
Expert Opinion on Pharmacotherapy: 1.703
Expert Opinion on Therapeutic Patents: 1.589 (up from 1.488)

Web Master: Marcus Hurley

JOURNAL EDITORS:

Current Medical Research and Opinion:

Malavika Legge, Publisher (UK/ROW)

Terri Metules, Managing Editor

Expert Opinion:

Elizabeth Knowles, Publisher

Elizabeth Knowles, Managing Editor

(EOP, Annals of Medicine, Original Research)

Fizah Khan, Commissioning Editor

(EOID, EOTT, EOBT)

Joris Roulleau, Senior Editor

(EODD, EOTP)

David Grech, Commissioning Editor

(EOMT, EODC, EODG)

Misty Bond, Commissioning Editor

(EOP, EODS, EOED)

All Other Journals:

Anna Treadway, Head of Journals Publishing

Disclaimer

Acceptance Of Informa Healthcare Blog Rules

These rules (the “Rules”) set out the terms for use of the Informa Healthcare Blog (the “Blog”), which apply to all users. Any submission of material and/or comments by you to the Blog means that you accept, and agree to abide by, all the terms and conditions of these Rules.
The Rules supplement our terms of website use (http://www.informahealthcare.com) and our privacy policy (http://www.informahealthcare.com/page/PrivacyPolicy).
The Informa Healthcare blog is a blog operated by Informa UK Limited. We are registered in England and Wales under company number 01072954 and we have our registered office at 37-41 Mortimer Street, London, W1T 3JH, United Kingdom. Our main trading address is Telephone House, 69-77 Paul Street, London, EC2A 4LQ, UK.
Moderation
As a professional publisher, we encourage informed communication and debate. We are keen to have a lively and informed range views that broaden and deepen debate while staying focussed on the central topic. For this reason, our Blog is fully moderated.
Every contribution submitted to the Blog (Contribution) will be checked by our moderators (normally the journal's Editors/Managing Editors) for compliance with our content standards set out below (Content Standards) before it is published. We will try to publish as many Contributions as we can but we cannot guarantee that all Contributions will be published. We also cannot guarantee how quickly Contributions will be posted on the Blog as this will depend on other editorial commitments.
Although the Blog is fully moderated, we are under no obligation to you or any other person to oversee, monitor or moderate the Blog or any other service we provide on our site and we may stop moderating the Blog at any time. We reserve the right to remove, or to disable access to, any Contribution which we deem to be potentially defamatory of any person or which we deem unlawful or in violation of any third party rights. We expressly exclude our liability for any loss or damage arising from the use of the Blog by any person in contravention of these Rules.
Minors
You must be aged 18 or over to use the Blog and the use of the Blog by a minor is prohibited.
Content Standards
These Content Standards apply to each part of a Contribution as well as to its whole. The Content Standards must be complied with in spirit as well as to the letter. Informa will determine, in its discretion, whether a Contribution breaches the Content Standards.
Please do not;
• make multiple postings. So that we can publish comments from as many different people as possible, participants should keep their number of contributions per debate to a reasonable level. Multiple posts from one individual, or small number of individuals, discourages many others who might otherwise wish to take part.
• Spam by reposting the same message, or very similar messages, more than once.
• Publicise or attempt to publicise anyone else’s contact details or compromise anyone else’s privacy in any way.
• Use any name other than your bona fide family name
In addition, please do not submit Contributions which:
• are irrelevant and/or lower the value of the debate as these will not be posted.
• include advertisements, promotions of products or services or which include any third party links
• are in any language other than English
• are in full capital letters
In addition, a Contribution must:
• Be accurate (where it states facts).
• Be genuinely held (where it states opinions).
• Comply with the law applicable in England and Wales and in any country from which it is posted.
• Be relevant.
A Contribution must not:
• Be defamatory of any person.
• Be obscene, offensive, hateful or inflammatory.
• Promote discrimination based on race, sex, religion, nationality, disability, sexual orientation or age.
• Disclose the name, address, telephone, mobile or fax number, e-mail address or any other personal data in respect of any individual.
• Infringe any copyright, database right or trade mark of any other person.
• Breach any legal duty owed to a third party, such as a contractual duty or a duty of confidence.
• Be in contempt of court.
• Be likely to harass, upset, embarrass, alarm or annoy any other person.
• Impersonate any person, or misrepresent your identity or affiliation with any person.
• Give the impression that the Contribution emanates from Informa if this is not the case.
• Advocate, promote, incite any third party to commit, or assist any unlawful or criminal act.
• Contain a statement which you know or believe, or have reasonable grounds for believing, that members of the public to whom the statement is, or is to be, published are likely to understand as a direct or indirect encouragement or other inducement to the commission, preparation or instigation of acts of terrorism.
• Contain any advertising or promote any services or web links to other sites.
Intellectual Property Rights
By submitting a Contribution to the Blog, you agree to grant Informa a non-exclusive licence to use that Contribution and all intellectual property (including copyright, designs, trade marks and database rights together “Intellectual Property”) contained within it. Although you will still own the Intellectual Property in your Contribution, Informa will have the right to freely use, edit, alter, adapt, create derivative works from, perform, play, reproduce, publish and/or distribute the material contained in your Contribution. This licence will be free of charge, perpetual and capable of sub-licence. Informa may exercise all Intellectual Property and publicity rights in the material contained in your Contribution in all jurisdictions, to their full extent and for the full period for which any such rights exist in that material. You also agree to waive all moral rights in relation to your Contribution for the purposes of the licence set out above.
Please also note that, in accordance with the Content Standards set out in these terms, you must ensure that your Contribution does not infringe any Intellectual Property right of any other person. By submitting your Contribution to the Blog, you are warranting that you have the right to grant Informa the non-exclusive copyright licence described above. You also warrant to take such steps as may be necessary to give effect to the licence granted above.
If you are not willing or in a position to grant such a licence to Informa, please do not submit the Contribution to the Blog.
Breach
When we consider that a breach of the Content Standards has occurred, we may at our discretion take such action as we deem appropriate. Failure to comply with these Rules constitutes a material breach of the terms of use on which you are permitted to use the Blog, and may result in our taking all or any of the following actions:
• Immediate, temporary or permanent withdrawal of your right to use the Blog.
• Immediate, temporary or permanent removal of any Contribution already posted on the Blog.
• Issue of a warning to you.
• Legal proceedings against you for reimbursement of all costs on an indemnity basis (including, but not limited to, reasonable administrative and legal costs) resulting from the breach.
• Further legal action against you.
• Disclosure of such information to law enforcement authorities as we reasonably feel is necessary or as required by law.
We exclude our liability for all action we may take in response to breaches of these Rules. The actions described above are not limited, and we may take any other action we reasonably deem appropriate.
Complaints
If you wish to complain about any Contribution posted to the Blog, please contact joris.roulleau@informa.com. We will then review the Contribution and decide whether it complies with our Content Standards. We will deal with any Contribution which, in our opinion, violates our Content Standards as described above (see section "Breach of these Rules"). We will inform you of the outcome of our review within a reasonable time of receiving your complaint.
Changes to these Rules
We may revise these Rules at any time. You are expected to check this page from time to time to take notice of any changes we make, as they are legally binding on you.

Monday, 13 December 2010

A Special Issue with a Special Offer: Downloads for Donations*

Wednesday, 8 December 2010

Of abstract importance – new abstract style for 2011

Saturday, 2 August 2008

Expert Opinion 2007 Impact Factors

New Blog

Twitter updates

Blog Archive

Subscribe to the Blog

Latest Articles

Our Journals

Label Cloud

Contact Us

Disclaimer